BridgeMD
New treatment option for Post-Traumatic Stress Disorder Complex
Official title Child-Parent Psychotherapy After the 2023 Kahramanmaraş Earthquake
ClinicalTrials.gov ID: NCT07040462
What this study is testing
- What it's testing
- This study aims to evaluate the effectiveness of Child-Parent Psychotherapy (CPP) in reducing trauma-related symptoms and improving attachment quality among preschool-aged children who experienced the 2023 Kahramanmaraş earthquakes in Türkiye. A total of 60 caregiver-child dyads (children aged 3-6) will be recruited from 11 earthquake-affected provinces.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Children aged 3 to 6 years old at the time of enrollment
- Resided in one of the 11 cities affected by the 2023 Kahramanmaraş earthquake (e.g., Hatay, Kahramanmaraş, Adıyaman, Malatya, Gaziantep, Şanlıurfa...
- Exposure to at least one qualifying traumatic event due to the earthquake (e.g., witnessing injury or death, loss of home, separation from caregiver)
- Living with a primary caregiver (mother or father) who consents to participate in the study
- Both caregiver and child are available to participate in 12 weekly sessions of CPP (online or face-to-face)
You likely can't join if
- Child or caregiver currently receiving psychotherapy or psychiatric treatment
- Child diagnosed with developmental disorder (e.g., autism, intellectual disability) that significantly impairs communication or relational functioning
- Caregiver with a diagnosed severe psychiatric disorder (e.g., psychosis, bipolar disorder) or active substance use disorder
- Families with ongoing legal custody disputes or instability that may interfere with consistent participation
- Inability to access internet or digital device (for participants assigned by chance to online therapy)
See the full eligibility criteria
- Children aged 3 to 6 years old at the time of enrollment
- Resided in one of the 11 cities affected by the 2023 Kahramanmaraş earthquake (e.g., Hatay, Kahramanmaraş, Adıyaman, Malatya, Gaziantep, Şanlıurfa, Adana, Osmaniye, Diyarbakır, Kilis, Elazığ)
- Exposure to at least one qualifying traumatic event due to the earthquake (e.g., witnessing injury or death, loss of home, separation from caregiver)
- Living with a primary caregiver (mother or father) who consents to participate in the study
- Both caregiver and child are available to participate in 12 weekly sessions of CPP (online or face-to-face)
- Caregiver is fluent in Turkish and able to complete self-report questionnaires
- Child or caregiver currently receiving psychotherapy or psychiatric treatment
- Child diagnosed with developmental disorder (e.g., autism, intellectual disability) that significantly impairs communication or relational functioning
- Caregiver with a diagnosed severe psychiatric disorder (e.g., psychosis, bipolar disorder) or active substance use disorder
- Families with ongoing legal custody disputes or instability that may interfere with consistent participation
- Inability to access internet or digital device (for participants assigned by chance to online therapy)
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.